Donald Abrams is an Ophthalmology physician affiliated with Sinai Hospital. OpenAlex indexes 19 publications with 1,263 citations (h-index 11); ClinicalTrials.gov lists 10 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2411 W Belvedere Ave
6th Floor
Baltimore, MD 212155228
Telephone
410-601-6480Registry record last updated 21 Nov 2007.
Clinical trials
- Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease
Sponsor: University of California, San Francisco
- Registry for Integrative Medicine Interventions Effectiveness
Sponsor: BraveNet
- Opioid and Cannabinoid Pharmacokinetic Interactions
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Dompe US, Inc.Program year20251 payment
- Thea Pharma Inc.Program year20231 payment
- Alcon Vision LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
82.4%Prostaglandin Analog46.3%Latanoprost79%Lumigan10%Travoprost9%Travatan Z3%Part D<11 patientsCarbonic Anhydrase Inhibitor24.7%Dorzolamide-Timolol38%Dorzolamide Hcl30%Brinzolamide18%Simbrinza14%Part D<11 patients+ 2 more classes in this area
Cardiovascular
11.2%Beta blocker11.2%Timolol Maleate100%Part D≥36 patientsAnti-infectives
5.3%Macrolide2.3%Erythromycin100%Part D<11 patientsFluoroquinolone Antibacterial1.8%Moxifloxacin100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparing Postoperative Intraocular Pressure Spikes in Disposable, Silicone Irrigation/Aspiration Tips Versus Reusable, Metal Irrigation/Aspiration Tips in Cataract Surgery
Investigative Ophthalmology & Visual Science
2014 - Glaucoma2003
- The Use of Complementary and Alternative Therapies
AACN Clinical Issues Advanced Practice in Acute & Critical Care
2000
Similar KOLs
Other experts from the same institution or the same specialty.
Henry Fein, MD
Sinai Hospital
Debra Counts, MD
Sinai Hospital
Ira Garonzik, MD
Sinai Hospital
David Tuchman, MD
Sinai Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”